Characterization of an Intravital Theranostic Imaging Camera (EANM 2026) - Sep 29, 2026 - Abstract #EP-1067; "Dosimetric and temporal performance was assessed through six-day longitudinal ¹⁷⁷Lu-PSMA-617 imaging of ex vivo human prostate cancer xenograft tissue... ITIC delivers quantitative, real-time radiopharmaceutical imaging at the mesoscale the scale at which therapeutic outcome is determined. This characterisation provides the quantitative foundation for intravital window chamber studies with direct, longitudinal access to radiotracer distribution, uptake kinetics, and dose heterogeneity within living tumour microenvironments."
Genito-urinary Cancer • Prostate Cancer • Solid Tumor
|
|
N. Rathod 1; K. Shi 1; A. Rominger 1; K. Pandya 1; J. Hu 1; R. Seifert 1; R. Ni 1; M. kruithof-de julio 1; J. Wang 1; C. Clement 1; J. Moore 2; B. Miller 2; B. Hunkeler 3; C. Mueller 3; A. Benechet 4; D. Viertl 5
|